Phage-display library screening services to develop in vivo gene therapy.
Ended Purchase Order Awarded Last action
- Contract number
- 75N92024P00129
- Awardee
-
Proteogenix UEI CP2GCU4XTVM7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $46,260
Award facts
- Contract value 100% obligated
- $46,260.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- France
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price Purchase Order to Proteogenix, a for-profit manufacturer, to provide phage-display library screening services to develop in vivo gene therapy. The contract has a potential value of $46,260.00 and a completion date of April 21, 2025. The contract was awarded on April 22, 2024 and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N92024P00129?
75N92024P00129 was awarded to Proteogenix by National Heart Lung and Blood Institute (National Institutes of Health) on April 22, 2024.
How much is contract 75N92024P00129 worth?
The government has obligated $46,260 on 75N92024P00129.
Was contract 75N92024P00129 competed?
The extent of competition for 75N92024P00129 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award